N
Patient 1
(B)(4). (B)(6).
| Seq | Brand | Generic | Manufacturer | Product code | Model | Catalog | Lot | PMA | 510(k) | Implant | Evaluated | Availability |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IGM ANTIBODIES TO CYTOMEGALOVIRUS (CMV IGM) | ENZYME LINKED IMMUNOABSORBENT ASSAY, CYTOMEGALOVIRUS | ROCHE DIAGNOSTICS | LFZ | NA | 04784618190 | 176724 | R | Y |
| Sequence | Received | Treatment | Outcome |
|---|---|---|---|
| 1 | 2017-12-06 | 0 |
Patient 1
(B)(4). (B)(6).
Patient 1
THE CUSTOMER RECEIVED A (B)(6) ELECSYS CMV IGM IMMUNOASSAY RESULT FOR ONE PATIENT SAMPLE. THE RESULT FROM A COBAS 6000 E 601 MODULE WAS (B)(6). NO SPECIFIC RESULT WAS PROVIDED. THE RESULT WAS REPORTED TO THE PATIENT'S PHYSICIAN, BUT AS IT WAS DISCREPANT FROM THE PREVIOUS RESULT FOR THE PATIENT THE SAMPLE WAS REPEATED. THE SAMPLE WAS REPEATED AND THE RESULT FROM VIDAS, LIASON XL, AND ANOTHER UNKNOWN ANALYZER WERE ALL (B)(6). NO SPECIFIC RESULTS WERE PROVIDED. THERE WAS NO ALLEGATION OF AN ADVERSE EVENT. THE PATIENT'S DIAGNOSIS WAS NOT AFFECTED. THE ANALYZER SERIAL NUMBER WAS REQUESTED BUT WAS NOT PROVIDED.